Calpain S-2 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human Calpain small subunit 2 (CAPNS2, UniProt Q96L46), expressed in HEK293 cells. Suited for calpain complex reconstitution, substrate cleavage studies, inhibitor profiling, and antibody validation.
Expression system
HEK293
Cat. #
REC-CalpainS2

In stock

SKU
REC-CalpainS2
$498.00

Target Overview

Calpain small subunit 2 (CAPNS2; UniProt Q96L46) is a 248-amino-acid calcium-dependent regulatory subunit belonging to the calpain family of non-lysosomal cysteine proteases. Unlike the ubiquitously expressed small subunit CAPNS1, CAPNS2 shows a more restricted tissue distribution and is considered a candidate tissue-specific chaperone for cognate large catalytic subunits, facilitating their correct folding and conferring calcium-regulated proteolytic activity toward substrates involved in cytoskeletal remodeling and signal transduction. The protein localises to the cytoplasm and participates in limited, rather than processive, proteolysis — a hallmark of calpain-family enzymes. This recombinant is produced in HEK293 cells, providing the mammalian post-translational processing environment — including glycosylation machinery and molecular chaperones — that is relevant to the study of a subunit whose primary proposed function is conformational chaperoning. Full-length sequence (residues 1–248) is expressed, reflecting the complete small-subunit domain architecture. Researchers use this recombinant in several contexts: (1) reconstitution of heterodimeric calpain complexes in vitro to measure calcium-dependent proteolytic activity against defined substrates; (2) small-molecule inhibitor profiling, where the correctly folded small subunit is required for physiologically relevant complex assembly; (3) biophysical characterisation of subunit–subunit interactions by SPR or ITC; and (4) as a defined positive-control antigen for antibody validation by Western blot or ELISA. Researchers validating detection reagents can pair this recombinant with the matched Triple Point Biologics antibody (SKU: RP-CalpainS2), which has been validated for Western blot against human targets. Validated human species reactivity is confirmed; additional species reactivity has not been independently established for this reagent.

Background

Calpains are a family of calcium-activated, cytoplasmic cysteine proteases that execute limited proteolysis of target substrates rather than complete degradation — a feature that distinguishes them from lysosomal or proteasomal degradation pathways. The canonical calpain holoenzyme is a heterodimer comprising a large catalytic subunit and a small regulatory subunit. CAPNS1, the prototypical small subunit, is ubiquitously expressed and supports the activity of calpains-1 and -2. CAPNS2 (gene: CAPNS2; also catalogued as CSS2) is a paralogue whose expression is more tissue-restricted. The UniProt annotation for Q96L46 describes CAPNS2 as a probable tissue-specific chaperone, raising the possibility that it supports the stability and calcium-regulated folding of large catalytic subunits in a context-dependent manner. Because calpains cleave a wide range of substrates — including focal adhesion kinase (FAK), talin, spectrin, and various signalling intermediates — they have been studied extensively in the context of cytoskeletal dynamics, cell migration, and anoikis resistance. Dysregulation of calpain activity has been investigated as a contributing factor in neurodegenerative conditions, muscular dystrophies, ischaemia-reperfusion injury, and oncogenic signalling. CAPNS2 specifically has been identified as a research target in studies examining tissue-specific regulation of calpain-dependent proteolysis, though its precise substrate repertoire and physiological binding partners remain active areas of investigation. From a reagent standpoint, the availability of a recombinant CAPNS2 produced in a mammalian expression system is important for several reasons. First, reconstitution experiments designed to test whether CAPNS2 can functionally substitute for CAPNS1 in supporting large-subunit activity require a well-folded, soluble small subunit. Second, interaction studies mapping the association between CAPNS2 and specific calpain large subunits benefit from full-length, mammalian-expressed material. Third, the development and validation of detection antibodies — including immunoprecipitation-grade and IHC-compatible antibodies — requires a defined, well-characterised antigen. Triple Point Biologics has produced proteinase and inhibitor antibodies since 1994; the companion antibody (RP-CalpainS2), validated for Western blot against human CAPNS2, is cross-linked to this recombinant on the product page for straightforward pairing in antibody validation workflows.

Applications

  • Reconstitution of heterodimeric calpain complexes for in vitro calcium-dependent proteolytic activity measurement
  • Inhibitor IC50 determination in complex-reconstitution assays requiring correctly folded small subunit
  • Substrate identification and cleavage-site mapping by mass spectrometry using reconstituted calpain holoenzyme
  • Antibody validation positive control for Western blot using matched TPB antibody (RP-CalpainS2)
  • Antigen coating for ELISA-based antibody characterisation and titer determination
  • Biophysical characterisation of CAPNS2–large-subunit interactions by surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC)
  • Pull-down and co-immunoprecipitation studies to map CAPNS2 protein–protein interaction networks

References

  1. No directly relevant PubMed citations for CAPNS2/Calpain S-2 were present in the provided reference set. References will be updated as primary literature specifically characterising CAPNS2 function and reagent use is identified. All citations listed on this page are drawn exclusively from the provided PubMed record set per catalog policy.

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Cytoplasm; Ca²⁺-activated

Frequently Asked Questions

What molecular weight band should Calpain S-2 (Recombinant) run at on SDS-PAGE and Western blot?

The full-length CAPNS2 polypeptide is 248 amino acids with a calculated molecular weight of ~28 kDa. On reducing SDS-PAGE, the recombinant produced in HEK293 cells typically migrates at approximately 30–32 kDa due to mammalian glycosylation and post-translational modifications. On Western blot using our matched antibody RP-CalpainS2, expect a single predominant band in that range. Anomalous migration slightly above predicted MW is common for this subunit and is not indicative of degradation or impurity. Purity is confirmed >90% by silver-stained SDS-PAGE.

Is Calpain S-2 (Recombinant) the same isoform as CAPNS1, and what distinguishes it functionally?

No — CAPNS2 (UniProt Q96L46) is a paralog of the ubiquitously expressed small subunit CAPNS1, sharing the same domain architecture but displaying a more restricted tissue distribution. Unlike CAPNS1, CAPNS2 is considered a candidate tissue-specific chaperone for cognate large catalytic calpain subunits. This recombinant is produced as the full-length 248-aa CAPNS2 sequence and has not been truncated or domain-swapped. Researchers working on tissue-specific calpain complexes or comparing small-subunit isoform function should ensure they are not substituting CAPNS1 reagents for CAPNS2 — the two are not functionally interchangeable in all contexts.

What substrates and assay formats are recommended for measuring Calpain S-2 (Recombinant) proteolytic activity?

As a regulatory small subunit, CAPNS2 itself does not carry the catalytic cysteine — proteolytic activity requires reconstitution with a cognate large catalytic subunit (e.g., calpain-1 or calpain-2 heavy chain). To measure activity of reconstituted complexes, fluorogenic peptide substrates such as Suc-LLVY-AMC or Z-Leu-Arg-AMC (ex/em 380/460 nm) are standard. Assays should be run in the presence of 0.5–5 mM CaCl₂ in 50 mM Tris-HCl pH 7.5, 150 mM NaCl. Include a no-calcium control to confirm calcium-dependence. Starting complex concentration of 50–200 nM is typical for initial titration.

What buffer conditions should I use for Calpain S-2 (Recombinant) activity assays or protein-protein interaction studies?

The protein is shipped in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol — this storage buffer is compatible with most downstream assays without prior exchange. For calcium-dependent activity assays with a reconstituted large subunit, supplement with 0.5–5 mM CaCl₂ and 2 mM DTT to maintain cysteine protease activity. For pull-down or SPR binding studies of subunit–subunit interactions, dilute into the same base buffer supplemented with 0.05% Tween-20 and 1 mg/mL BSA to reduce nonspecific binding. Avoid EDTA-containing buffers, which will chelate calcium and abolish activity.

What starting concentration of Calpain S-2 (Recombinant) is recommended for reconstitution and dose-response experiments?

For reconstitution with a large catalytic calpain subunit, begin with equimolar small-to-large subunit ratios at 100–500 nM total protein and titrate based on measured substrate turnover. For inhibitor IC₅₀ determination in reconstituted complex assays, use the lowest enzyme concentration that gives a robust, linear signal window — typically 50–150 nM complex — to avoid enzyme excess artifacts that artificially elevate apparent IC₅₀. For Western blot positive controls, 50–200 ng loaded per lane is sufficient for detection with the matched RP-CalpainS2 antibody without saturating the signal.

Can I use Calpain S-2 (Recombinant) as a positive control for Western blot with the RP-CalpainS2 antibody?

Yes — this is one of the primary intended uses of pairing REC-CalpainS2 with the matched rabbit polyclonal RP-CalpainS2. Load 50–200 ng of recombinant per lane on a 12–15% SDS-PAGE gel under reducing conditions. The antibody (see /anti-calpain-s2-rabbit-polyclonal-antibody) is validated for Western blot and should resolve a clean band at ~30–32 kDa. This pairing also serves as a system-level positive control when validating RP-CalpainS2 for detection of endogenous CAPNS2 in tissue lysates, confirming both antibody reactivity and correct band assignment before committing to immunoprecipitation or IHC workflows.

How much Calpain S-2 (Recombinant) should I load for antibody validation Western blot alongside cell lysate?

Load 50–100 ng of REC-CalpainS2 in a dedicated lane adjacent to your cell or tissue lysate. At this amount, the RP-CalpainS2 rabbit polyclonal antibody provides a strong reference band at ~30–32 kDa under standard ECL detection. Running the recombinant alongside endogenous samples lets you confirm co-migration of the endogenous band with the recombinant standard — an important control given that CAPNS2 tissue distribution is restricted and endogenous signal strength varies considerably by cell type. Avoid loading more than 200 ng per lane, as signal saturation can obscure the comparison.

How should I store and handle Calpain S-2 (Recombinant) to maintain stability and avoid activity loss?

Store at −20°C in the single-use aliquots provided. The formulation in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol is designed to maintain protein integrity through the freeze-thaw cycle, but repeated freeze-thaw significantly degrades both structural integrity and subunit-interaction capacity — do not refreeze thawed aliquots. On ice, the thawed protein is stable for 4–8 hours for same-day experiments. If longer bench stability is required, supplement with 0.1% BSA as a carrier. Endotoxin is confirmed <0.1 EU/µg by LAL assay, so no additional depyrogenation step is needed for cell-based assays.

Validation imagery coming soon

Western blot validation figures for REC-CalpainS2 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →